Your search for tofacitinib returned 3 results

By identifying existing medications that may be repurposed for dementia, clinicians may be able to provide faster treatment for those in need.

The approval was based on data from a phase 3 study which evaluated tofacitinib in adults with active AS who had an inadequate response to at least 2 NSAIDs.

The update follows the FDA’s Drug Safety Communication, which was based on a completed review of a large randomized safety clinical trial evaluating tofacitinib in patients with rheumatoid arthritis.